Citius Pharmaceuticals, Inc. Gain (Loss) on Extinguishment of Debt
Citius Pharmaceuticals, Inc. (CTXR) reported Gain (Loss) on Extinguishment of Debt of $2.39 million for the 12-month period ending 2024-09-30, per its 10-K filed 2024-12-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2024-12-27
- Citius Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was $0.00.
- Citius Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-03-31 was $2.39M.
- Citius Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Citius Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for fiscal 2024 was $2.39M, a 33.41% decline from fiscal 2023.
- Citius Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was $3.59M.
- Citius Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $166.56K.
- Citius Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for fiscal 2018 was $450.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 1 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | $0.00 derived: sum of 2 quarters · filed 2024-12-27 | $2.39M derived: sum of 3 quarters · filed 2024-12-27 | $2.39M 10-K · filed 2024-12-27 | |
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-12 | $2.39M derived: sum of 2 quarters · filed 2024-08-12 | $2.39M 10-Q · filed 2024-08-12 | $2.39M derived: sum of 4 quarters · filed 2024-12-27 | |
| 2024-03-31 | $2.39M 10-Q · filed 2024-05-14 | $2.39M 10-Q · filed 2024-05-14 | $2.39M derived: sum of 3 quarters · filed 2024-12-27 | $2.39M derived: sum of 4 quarters · filed 2024-12-27 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2024-12-27 | $0.00 derived: sum of 2 quarters · filed 2024-12-27 | $0.00 derived: sum of 3 quarters · filed 2024-12-27 | $0.00 derived: sum of 4 quarters · filed 2024-12-27 | |
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | $0.00 derived: sum of 2 quarters · filed 2024-12-27 | $0.00 derived: sum of 3 quarters · filed 2024-12-27 | $3.59M 10-K · filed 2024-12-27 | |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-12 | $0.00 derived: sum of 2 quarters · filed 2024-08-12 | $3.59M 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-14 | $3.59M 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $3.59M 10-Q · filed 2024-02-14 | ||||
| 2021-09-30 | $166.56K 10-K · filed 2022-12-22 | ||||
| 2021-07-28 | $166.56K 10-K · filed 2022-12-22 | ||||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $0.00 derived: sum of 2 quarters · filed 2019-12-16 | $450.00K derived: sum of 3 quarters · filed 2019-12-16 | $450.00K 10-K · filed 2019-12-16 | |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $450.00K derived: sum of 2 quarters · filed 2019-08-14 | $450.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $450.00K 10-Q · filed 2019-05-15 | $450.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |